• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIG-Syn:一种用于预测协同药物组合的超图与交互感知多粒度网络。

HIG-Syn: a hypergraph and interaction-aware multigranularity network for predicting synergistic drug combinations.

作者信息

Gu Yuexi, Zu Jian, Sun Yongheng, Zhang Louxin

机构信息

School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, People's Republic of China.

Department of Mathematics and Centre for Data Science and Machine Learning, National University of Singapore, Singapore 119076, Singapore.

出版信息

Bioinformatics. 2025 Jul 1;41(Supplement_1):i86-i95. doi: 10.1093/bioinformatics/btaf215.

DOI:10.1093/bioinformatics/btaf215
PMID:40662801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12261487/
Abstract

MOTIVATION

Drug combinations can not only enhance drug efficacy but also effectively reduce toxic side effects and mitigate drug resistance. With the advancement of drug combination screening technologies, large amounts of data have been generated. The availability of large data enables researchers to develop deep learning methods for predicting drug targets for synergistic combination. However, these methods still lack sufficient accuracy for practical use, and most overlook the biological significance of their models.

RESULTS

We propose the HIG-Syn (hypergraph and interaction-aware multigranularity network for drug synergy prediction) model, which integrates a coarse-granularity module and a fine-granularity module to predict drug combination synergy. The former utilizes a hypergraph to capture global features, while the latter employs interaction-aware attention to simulate biological processes by modeling substructure-substructure and substructure-cell line interactions. HIG-Syn outperforms state-of-the-art machine learning models on our validation datasets extracted from the DrugComb and GDSC2 databases. Furthermore, the fact that five of the 12 novel synergistic drug combinations predicted by HIG-Syn are strongly supported by experimental evidence in the literature underscores its practical potential.

AVAILABILITY AND IMPLEMENTATION

The source code is available at https://github.com/gracygyx/HIGSyn.

摘要

动机

药物组合不仅可以提高药物疗效,还能有效降低毒副作用并减轻耐药性。随着药物组合筛选技术的进步,已产生了大量数据。大数据的可用性使研究人员能够开发深度学习方法来预测协同组合的药物靶点。然而,这些方法在实际应用中仍缺乏足够的准确性,并且大多数方法忽略了其模型的生物学意义。

结果

我们提出了HIG-Syn(用于药物协同作用预测的超图和交互感知多粒度网络)模型,该模型集成了粗粒度模块和细粒度模块来预测药物组合的协同作用。前者利用超图捕获全局特征,而后者采用交互感知注意力通过对亚结构-亚结构和亚结构-细胞系相互作用进行建模来模拟生物学过程。在我们从DrugComb和GDSC2数据库中提取的验证数据集上,HIG-Syn的性能优于当前最先进的机器学习模型。此外,HIG-Syn预测的12种新型协同药物组合中有5种得到了文献中实验证据的有力支持,这突出了其实际应用潜力。

可用性和实现方式

源代码可在https://github.com/gracygyx/HIGSyn获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/fd7ffc18d536/btaf215f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/6459422d3185/btaf215f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/77b8ba4818f1/btaf215f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/b4d9a7f19326/btaf215f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/451b0cc50dba/btaf215f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/06d106b38adf/btaf215f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/fd7ffc18d536/btaf215f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/6459422d3185/btaf215f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/77b8ba4818f1/btaf215f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/b4d9a7f19326/btaf215f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/451b0cc50dba/btaf215f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/06d106b38adf/btaf215f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/12261487/fd7ffc18d536/btaf215f6.jpg

相似文献

1
HIG-Syn: a hypergraph and interaction-aware multigranularity network for predicting synergistic drug combinations.HIG-Syn:一种用于预测协同药物组合的超图与交互感知多粒度网络。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i86-i95. doi: 10.1093/bioinformatics/btaf215.
2
MADSP: predicting anti-cancer drug synergy through multi-source integration and attention-based representation learning.MADSP:通过多源整合和基于注意力的表征学习预测抗癌药物协同作用
Bioinformatics. 2025 Jun 2;41(6). doi: 10.1093/bioinformatics/btaf326.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Short-Term Memory Impairment短期记忆障碍
6
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
7
Lightweight cross-resolution coarse-to-fine network for efficient deformable medical image registration.用于高效可变形医学图像配准的轻量级跨分辨率粗到细网络
Med Phys. 2025 Apr 25. doi: 10.1002/mp.17827.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
EM-PLA: environment-aware heterogeneous graph-based multimodal protein-ligand binding affinity prediction.EM-PLA:基于环境感知异构图的多模态蛋白质-配体结合亲和力预测
Bioinformatics. 2025 Jul 1;41(7). doi: 10.1093/bioinformatics/btaf298.
10
Accurate PROTAC-targeted degradation prediction with DegradeMaster.使用DegradeMaster进行准确的PROTAC靶向降解预测。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i342-i351. doi: 10.1093/bioinformatics/btaf191.

本文引用的文献

1
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response.对于进展期或反应欠佳的骨髓纤维化患者,在芦可替尼基础上加用维奈托克。
Blood Neoplasia. 2024 Nov 2;2(1):100056. doi: 10.1016/j.bneo.2024.100056. eCollection 2025 Feb.
2
The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.双重BCL-2和BCL-XL抑制剂AZD4320在B细胞前体急性淋巴细胞白血病中作用于靶点并与MCL-1抑制协同作用。
Blood Adv. 2024 Dec 10;8(23):6035-6042. doi: 10.1182/bloodadvances.2024013194.
3
Hi-GeoMVP: a hierarchical geometry-enhanced deep learning model for drug response prediction.
Hi-GeoMVP:一种分层几何增强的深度学习模型,用于药物反应预测。
Bioinformatics. 2024 Mar 29;40(4). doi: 10.1093/bioinformatics/btae204.
4
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.大规模泛癌种细胞系筛查鉴定出潜在可用药和有效药物组合。
Cancer Discov. 2024 May 1;14(5):846-865. doi: 10.1158/2159-8290.CD-23-0388.
5
DrugBank 6.0: the DrugBank Knowledgebase for 2024.DrugBank 6.0:2024 年版 DrugBank 知识库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1265-D1275. doi: 10.1093/nar/gkad976.
6
Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.多向关系增强超图表示学习在抗癌药物协同作用预测中的应用。
Bioinformatics. 2022 Oct 14;38(20):4782-4789. doi: 10.1093/bioinformatics/btac579.
7
Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model.在器官型三阴性乳腺癌模型中靶向基质-肿瘤 HGF-MET 信号传导的治疗。
Mol Cancer Res. 2022 Jul 6;20(7):1166-1177. doi: 10.1158/1541-7786.MCR-21-0317.
8
Effective drug combinations in breast, colon and pancreatic cancer cells.在乳腺癌、结肠癌和胰腺癌细胞中有效的药物组合。
Nature. 2022 Mar;603(7899):166-173. doi: 10.1038/s41586-022-04437-2. Epub 2022 Feb 23.
9
Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity.依托泊苷诱导的 DNA 损伤在 p53 突变体中增加:鉴定影响 p53 突变对拓扑异构酶 2 诱导细胞毒性的 ATR 和其他基因。
Oncotarget. 2022 Feb 14;13:332-346. doi: 10.18632/oncotarget.28195. eCollection 2022.
10
A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC.一种使用长春新碱和ALK抑制剂使EML4-ALK阳性非小细胞肺癌致敏的联合治疗策略。
Cancers (Basel). 2022 Feb 2;14(3):779. doi: 10.3390/cancers14030779.